Monika Fischer, MD, reviewing Sandborn WJ, et al. Gastroenterology 2020 Feb 21. Upadacitinib, a selective Janus kinase 1 (Jak1) inhibitor (60-fold selective for Jak1 over
Selective Oral Jak1 Inhibitor
Selective Oral Jak1 Inhibitor
First Selective Oral Jak1 Inhibitor Induces Remission in Ulcerative Colitis
First Selective Oral Jak1 Inhibitor Induces Remission in Ulcerative Colitis
